Table of Contents
ISRN Stroke
Volume 2014 (2014), Article ID 313976, 4 pages
http://dx.doi.org/10.1155/2014/313976
Clinical Study

Experiences of Thrombolytic Therapy for Ischemic Stroke in Tuzla Canton, Bosnia and Herzegovina

Department of Neurology, University Clinical Center Tuzla, Medical Faculty, University of Tuzla, Trnovac bb, 75000 Tuzla, Bosnia and Herzegovina

Received 6 January 2014; Accepted 4 February 2014; Published 11 March 2014

Academic Editors: F. Corea, H.-M. Kwon, and A. Shuaib

Copyright © 2014 Dževdet Smajlović et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. R. Lees, E. Bluhmki, R. von Kummer et al., “Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials,” The Lancet, vol. 375, no. 9727, pp. 1695–1703, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. N. Wahlgren, N. Ahmed, A. Dávalos et al., “Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study,” The Lancet, vol. 369, no. 9558, pp. 275–282, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. N. Wahlgren, N. Ahmed, A. Dávalos et al., “Thrombolysis with alteplase 3-4·5 h after acute ischaemic stroke (SITS-ISTR): an observational study,” The Lancet, vol. 372, no. 9646, pp. 1303–1309, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. H. P. Adams Jr., B. H. Bendixen, L. J. Kappelle et al., “Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial,” Stroke, vol. 24, no. 1, pp. 35–41, 1993. View at Google Scholar · View at Scopus
  5. M. Roje-Bedeković, V. Vargek-Solter, L. Čorić et al., “Thrombolysis for acute ischemic stroke—our experiences as part of SITS-MOST,” Acta Clinica Croatica, vol. 48, no. 3, pp. 287–293, 2009. View at Google Scholar · View at Scopus
  6. B. C. V. Campbell, C. Costello, S. Christensen et al., “Fluid-attenuated inversion recovery hyperintensity in acute ischemic stroke may not predict hemorrhagic transformation,” Cerebrovascular Diseases, vol. 32, no. 4, pp. 401–405, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. V. Bogosavljevic, M. Bodenant, L. Beslac-Bumbasirevic et al., “Intravenous thrombolysis for acute cerebral ischemia in Belgrade, Serbia: comparison with Lille, France,” European Neurology, vol. 66, no. 1, pp. 30–36, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. T. Litwin, A. Kobayashi, M. Skowrońska, and A. Członkowska, “Thrombolysis in acute ischaemic stroke within 3 hours of symptom onset: a report of the first 100 cases,” Neurologia i Neurochirurgia Polska, vol. 42, no. 1, pp. 1–5, 2008. View at Google Scholar · View at Scopus
  9. K. M. Chapman, A. R. Woolfenden, D. Graeb et al., “Intravenous tissue plasminogen activator for acute ischemic stroke: a Canadian hospital's experience,” Stroke, vol. 31, no. 12, pp. 2920–2924, 2000. View at Google Scholar · View at Scopus
  10. R. Mikulík, P. Kadlecová;, A. Czlonkowska et al., “Factors influencing in-hospital delay in treatment with intravenous thrombolysis,” Stroke, vol. 43, pp. 1578–1583, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Dávalos, J. Alvarez-Sabin, J. L. Martí-Vilalta, and J. Castillo, “Intravenous tissue-type plasminogen activator for the treatment of acute cerebral ischemia,” Medicina Clínica, vol. 120, no. 1, pp. 1–5, 2003. View at Google Scholar
  12. N. Galldiks, O. Zaro-Weber, C. Dohmen et al., “Systemic thrombolysis with rt-PA in patients under 40 years of age: a subgroup analysis of the Cologne stroke experience,” Cerebrovascular Diseases, vol. 30, no. 5, pp. 514–518, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. J. R. Marler, “Tissue plasminogen activator for acute ischemic stroke,” The New England Journal of Medicine, vol. 333, no. 24, pp. 1581–1587, 1995. View at Publisher · View at Google Scholar · View at Scopus